Viemed Healthcare, Inc. (NASDAQ:VMD) Q4 2023 Earnings Call Transcript

Eric Coldwell: Are you willing to share who you’re rerouting to? What other payer switches you’re using?

Todd Zehnder: I mean, currently, our- I don’t mind saying that currently, the largest reroute is going to waste or slashes our med. I think it’s one and the same, but- that’s probably our second largest. And then all of our federal monies are directly with CMS, so that’s not impacted.

Eric Coldwell: So you’re not anticipating a notable impact on cash flow this quarter, which I think is the knock-on effect that most of our supply chain coverage is focused on, but it doesn’t sound like it’s a material concern in whatever it is, is likely transitory?

Todd Zehnder: Yes, assuming that all of our efforts that are ongoing come through that cash flows are as we are expected, we shouldn’t see a material impact. It may slow down some cash for a little while, but nothing that’s going to hamper our ability to continue to do anything around here.

Eric Coldwell: Perfect. Let me add my congrats to a nice continued performance. Good talking to you guys. Thanks very much.

Todd Zehnder: Thanks Eric. Have a good day, man.

Operator: Thank you. And there are no further questions at this time. I’ll hand the floor back to management for closing remarks. Thank you.

Todd Zehnder: Yes. We want to thank everybody for your interest in Viemed today. And if there are any follow-ups, just reach out to us. Have a great day.

Operator: Thank you. This concludes today’s conference. All parties may disconnect.